Connect with us

International

Europe publishes its first official monograph on the cannabis flower

Published

em

Cannabis flower. Photo: Laura Ramos | Cannareporter

A European Pharmacopoeia Commission, held last June, revealed the first official monograph on the cannabis flower, marking a significant milestone in the field of pharmacology and healthcare on the European continent. This decision could revolutionize the landscape of herbal medicines in Europe, serving as a beacon of guidance for health authorities and companies in the cannabis industry. The official implementation of the monograph (which you can consult at the end of this article) is scheduled for July 1, 2024.

The adoption of this monograph on the cannabis flower is a testament to the evolution of the herbal medicine landscape. As a beacon of guidance, this document describes the fundamental specifications for herbal medicines, focusing particularly on the cannabis flower. What makes this development even more notable is its integration into the widely recognized European Pharmacopoeia (Ph. Eur.) Supplement 11.5, which is scheduled for publication in January 2024.

Browse the monograph: A Comprehensive Guide to the Cannabis Flower

This newly created monograph delves into the nuances of the cannabis flower, offering valuable information on the proper collection and processing of dried cannabis samples. Designed to be used in conjunction with the general monograph on herbal medicines, it not only provides cannabis-specific guidelines but also incorporates relevant requirements.

Empowering the medical community

The European Directorate for the Quality of Medicines and Healthcare (EDQM) is at the forefront of this transformative initiative. To disseminate knowledge and ensure seamless implementation, the organization plans to hold a webinar for its members on December 14, 2023. This webinar will serve as a platform to uncover the intricacies of the new monograph on the cannabis flower, empowering healthcare professionals with the latest information.

As the dust settles after the revelation of this pioneering document, the practical implications become evident. The official implementation of this monograph is scheduled for July 1, 2024. This deadline allows stakeholders, including healthcare providers and researchers, to prepare for the paradigm shift in prescribing practices and medical standards. plant based.

Addressing concerns: A holistic approach to patient safety

One of the main highlights of this monograph on cannabis flowers is its comprehensive approach to patient safety. Based on information from several national authorities, the monograph incorporates strict limits for substances such as arsenic, cadmium and lead. These limits serve as a safeguard, ensuring that herbal medicines prescribed to patients meet the highest standards of quality and safety.

The introduction of the cannabis flower monograph into the European Pharmacopoeia marks a decisive moment in the field of herbal medicine. Its integration into established pharmacopoeial standards means a new era of precision and excellence. As we eagerly anticipate its implementation in 2024, the medical community is poised to embrace this monumental shift, shaping the future of herbal medicine and patient care.

While the official version of the monograph is not published below, the informative version of it can be consulted, as well as the appendix that includes informative chromatograms.

Monograph - Cannabis flower 3028

Click here to comment
Subscribe
Notify of
0 Comments
Inline feedback
View all comments
Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Press Releases24 hours ago

Porto, Matosinhos, Valongo and Paredes – Eight arrested for drug trafficking and more than 8000 doses of drugs seized

The Porto Territorial Command, through the Criminal Investigation Center (NIC) of Santo Tirso, between the 20th and...

National2 days ago

Portugal: GNR seizes 3 tons of hashish in the Guadiana River

The Coastal and Border Control Unit (UCCF) of the National Republican Guard (GNR) seized last Friday, the 23rd...

Events2 days ago

Spannabis 2024: Barcelona hosts the 20th edition of the largest cannabis exhibition in the world, from March 15th to 17th

Barcelona is preparing to host the 20th edition of Spannabis, the largest cannabis fair in the world, on the 15th,...

International6 days ago

Germany: Bundestag voted today in favor of legalizing cannabis, but Federal Council approval is still needed

The Bundestag debated and voted this afternoon on the project to legalize the personal use of cannabis in the country, with 407...

International7 days ago

Germany: Legalization will be discussed this Friday, the 23rd

The German Bundestag will finally deliberate on the legalization of cannabis for personal consumption in the country. The debate, which has been...

Hemp1 weeks ago

Hemp cultivation in the Azores will have an information session on Terceira Island

The Confraria Internacional Cannabis Portugal and CannAzores join forces to promote an Information Session on the Cultivation of...

Health2 weeks ago

CBD and CBC show promising results in head and neck squamous cell carcinoma

A study published in the journal Cancers found that cannabis extracts rich in CBD (cannabidiol) can kill breast cancer cells...

International2 weeks ago

Ukraine: Zelensky signs bill to legalize medical cannabis

Ukrainian President Volodymyr Zelensky signed a bill legalizing medical cannabis in Ukraine, with the expectation that...

National3 weeks ago

Portugal: Associação Mães pela Canábis publishes e-book on medicinal cannabis

The Association of Mothers for Cannabis (AMC) announced the launch of an e-book entitled “Frontiers of Cannabis: SCIENCE, THERAPEUTICS &...

corporations4 weeks ago

Akanda signs letter of intent to sell RPK Biopharma to Somaí. “It will be one of the few vertical cannabis companies in the EU”, says Michael Sassano

Akanda Corporation, an international medical cannabis company listed on Nasdaq (AKAN) and which owns the Portuguese company Holigen, announced...